Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959840 · ClinicalTrials.gov registry record · Phase 4
Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean
A Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT02959840 is a Phase 4 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 180 participants.
The verdict
NCT02959840, a Phase 4 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of acupressure point P6 stimulation versus intravenous ondansetron plus metoclopramide versus no antiemetic prophylaxis during elective cesarean section under regional anesthesia.
Interventions
- DRUG Ondansetron
- DRUG Metoclopramide
- DEVICE Acupressure Point P6 stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-08-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02959840
The ClinicalTrials.gov registry entry for NCT02959840 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ondansetron is the first listed.
NCT02959840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02959840 about?
NCT02959840 is a clinical study titled "Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean". The purpose of this study is to compare the effectiveness of acupressure point P6 stimulation versus intravenous ondansetron plus metoclopramide versus no antiemetic prophylaxis during elective cesarean section under regional anesthesia.
What is the current status of trial NCT02959840?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2015-07. Estimated completion is 2017-08-23.
What interventions are being tested in trial NCT02959840?
The interventions under investigation include: Ondansetron (DRUG), Metoclopramide (DRUG), Acupressure Point P6 stimulator (DEVICE).
Who is sponsoring clinical trial NCT02959840?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.